Skip to content

Feasibility Study of Tumor Blood Flow Measurement by Detection of Positron Activation Post Proton Therapy (DS01)

Feasibility Study of Tumor Blood Flow Measurement by Detection of Positron Activation Post Proton Therapy

Status
Terminated
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01987193
Enrollment
3
Registered
2013-11-19
Start date
2012-07-31
Completion date
2018-05-31
Last updated
2018-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Brain Cancer, Lung Cancer, Prostate Cancer

Keywords

Proton radiation, tumor blood flow

Brief summary

The purpose of this study is the development of noninvasive (having no direct contact) detector and electronic system that will directly measure tumor blood flow rate.

Interventions

None listed

Sponsors

University of Florida
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Solid tumors in the intracranial, thoracic, or pelvic regions.

Exclusion criteria

N/A \-

Design outcomes

Primary

MeasureTime frame
Patients with hypoxic tumor identified by tumor blood flow measurement.3 months

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026